Methods of detecting sepsis
US-9493832-B2 · Nov 15, 2016 · US
US2015292013A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2015292013-A1 |
| Application number | US-201314442858-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 4, 2013 |
| Priority date | Nov 16, 2012 |
| Publication date | Oct 15, 2015 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to novel miRNA markers useful for diagnosis or therapy of disease, in particular for neuronal disorders such as Alzheimer's Disease (AD).
Opening claim text (preview).
1 . An isolated nucleic acid molecule comprising (a) a nucleotide sequence selected from the group of nucleotide sequences having a sequence according to SEQ ID NO 2, SEQ ID NO 1, and SEQ ID NO 3 to SEQ ID NO 365, (b) a nucleotide sequence which is the complement thereof, or (c) a nucleotide sequence which has an identity of at least 90% to a sequence of (a) or (b). 2 . The nucleic acid molecule according to claim 1 which is selected from the group consisting of RN…
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.